Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
39298 POSTS 0 COMMENTS
Adoption of a recommended bundle of prevention behaviors is associated with a reduction in the pediatric surgical site infection rate

Prevention Bundle Can Cut Rate of Pediatric SSIs

0
Twenty-one percent reduction in SSI rate reported across network hospitals
A nutrigenetic-based diet does not increase weight loss

Nutrigenetic-Based Diet Doesn’t Increase Weight Loss

0
But, genetic features identify patients likely to benefit from a balanced diet strategy
The incidence of cytomegalovirus infection/disease is reduced in de novo kidney transplant recipients receiving reduced dose tacrolimus and everolimus

Reduced-Dose Tacrolimus, Everolimus Cuts CMV Infection

0
Findings in de novo kidney recipients receiving no pharmacologic CMV prophylaxis
Menstrual preconditioning could prevent major obstetrical syndromes in women with polycystic ovary syndrome

Menstrual Preconditioning May Prevent PCOS-Tied Complications

0
Induction of ovulation should be preceded by period of progesterone withdrawal bleeding
Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat advanced cases of non-small-cell lung cancer with tumors that express the PD-L1 protein. Keytruda is approved for use with the PD-L1 IHC 22C3 pharmDx test

FDA Approves Keytruda for Advanced NSCLC

0
Approved for use with PD-L1 IHC 22C3 pharmDx test
Stage IV nonsmall-cell lung cancer patients in the United States often receive more radiation therapy than recommended

Palliative Radiotherapy Often Overused in Stage IV NSCLC

0
Not proven to further improve symptoms or quality of life; can have significant side effects
Most patients with acute lateral epicondylitis recover without physical therapy and steroid injections

No Benefit Seen With Physical Tx in Acute Lateral Epicondylitis

0
For most, PT plus placebo or steroid injection similar to no treatment at all
For patients with suspected nonceliac gluten sensitivity

Research Supports Theory of Nonceliac Gluten Sensitivity

0
Randomized, double-blind, placebo-controlled, cross-over trial shows symptoms with limited exposure
In order to minimize risk when practicing telemedicine

Providers Must Understand Legal Limits of Telemedicine

0
Providers should ensure they hold proper medical license and have medical liability coverage
A new treatment for melanoma that combines two cancer drugs has been approved by the U.S. Food and Drug Administration. The therapy for advanced melanoma includes the drugs Yervoy (ipilimumab) and Opdivo (nivolumab)

FDA Approves New Combo Therapy for Melanoma

0
Yervoy and Opdivo previously approved individually to treat melanoma